Patient-reported outcomes as a source of evidence in off-label prescribing: Analysis of data from PatientsLikeMe

Journal of Medical Internet Research

Volumn 13, Issue 1, 2011, Pages

  Frost, Jeana ^a   Okun, Sally ^b   Vaughan, Timothy ^b   Heywood, James ^b   Wicks, Paul ^b  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b PATIENTSLIKEME INC   (United States)

Author keywords

Internet; Methods; Off label; Online community; Patient platform; Research

Indexed keywords

AMITRIPTYLINE; BENZHYDRYL DERIVATIVE; MODAFINIL;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; COGNITIVE DEFECT; COMMUNITY CARE; DRUG EFFECT; FATIGUE; HUMAN; INTERNET; METABOLISM; OFF LABEL DRUG USE; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PATIENT; PATIENT CARE; SALIVA; SECRETION; SELF REPORT; SLEEP STAGE; TREATMENT OUTCOME; UTILIZATION REVIEW;

AMITRIPTYLINE; AMYOTROPHIC LATERAL SCLEROSIS; BENZHYDRYL COMPOUNDS; COGNITION DISORDERS; COMMUNITY NETWORKS; DECISION MAKING, ORGANIZATIONAL; FATIGUE; HUMANS; INTERNET; OFF-LABEL USE; PATIENT-CENTERED CARE; PATIENTS; SALIVA; SELF REPORT; SLEEP STAGES; TREATMENT OUTCOME;

EID: 79953094346     PISSN: None     EISSN: 14388871     Source Type: Journal    
DOI: 10.2196/jmir.1643     Document Type: Article

References (26)

1. Stafford RS. Regulating off-label drug use-rethinking the role of the FDA. N Engl J Med 2008 Apr 3;358(14):1427-1429 [FREE Full text] [doi: 10.1056/NEJMp0802107] [Medline: 18385495] (Pubitemid 351482734)
2. Food and Drug Administration. FDA. 2009. Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices URL: http://www.fda.gov/RegulatoryInformation/Guidances/ ucm125126.htm [accessed 2010-11-13] [WebCite Cache ID 5uCvY90AA]
3. Radley DC, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Intern Med 2006 May 8;166(9):1021-1026 [FREE Full text] [doi: 10.1001/archinte.166.9.1021] [Medline: 16682577]
4. Demonaco HJ, Ali A, Hippel E. The major role of clinicians in the discovery of off-label drug therapies. Pharmacotherapy 2006 Mar;26(3):323-332. [doi: 10.1592/phco.26.3.323] [Medline: 16503712] (Pubitemid 43334671)
5. Young A, Adams C. Knight Ridder/Tribune Information Services. 2003. Prescription For Danger: A Knight Ridder Special Report URL: http://www.anderson.ucla.edu/documents/areas/adm/loeb/04h17riskyrx.pdf [accessed 2010-11-13] [WebCite Cache ID 5uCwawOcQ]
6. Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry 2002 Feb;72(2):179-183 [FREE Full text] [Medline: 11796766]
7. Vedula SS, Bero L, Scherer RW, Dickersin K. Outcome reporting in industry-sponsored trials of gabapentin for off-label use. N Engl J Med 2009 Nov 12;361(20):1963-1971 [FREE Full text] [doi: 10.1056/NEJMsa0906126] [Medline: 19907043]
8. Devulapalli KK, Nasrallah HA. An analysis of the high psychotropic off-label use in psychiatric disorders: The majority of psychiatric diagnoses have no approved drug. Asian Journal of Psychiatry 2009;2(1):29-36. [doi: 10.1016/j.ajp.2009.01.00]
9. Mello MM, Studdert DM, Brennan TA. Shifting terrain in the regulation of off-label promotion of pharmaceuticals. N Engl J Med 2009 Apr 9;360(15):1557-1566. [doi: 10.1056/NEJMhle0807695] [Medline: 19357413]
10. Week BB. NewsRx.com. 2007. Clinical Trial Costs Top $26,000 Per Patient, New Study Says URL: http://www.newsrx.com/health-articles/418079.html [accessed 2010-12-22] [WebCite Cache ID 5vAWYTOsM]
11. Fox S. Pew Internet. Washington, DC: Pew Internet & American Life Project; 2009 Jun. The social life of health information URL: http://www.pewinternet.org/~/media//Files/Reports/2009/PIP-Health-2009.pdf [accessed 2010-12-22] [WebCite Cache ID 5vAWbD4n5]
12. Paul J, Seib R, Prescott T. The Internet and clinical trials: background, online resources, examples and issues. J Med Internet Res 2005;7(1):e5 [FREE Full text] [doi: 10.2196/jmir.7.1.e5] [Medline: 15829477]
13. Life Raft Group. liferaftgroup.org. 2009. Pathway to a Cure: LRG Patient Registry Research URL: http://www.liferaftgroup.org/research.html [accessed 2010-11-13] [WebCite Cache ID 5uCyWZfAL]
14. Frost JH, Massagli MP. Social uses of personal health information within PatientsLikeMe, an online patient community: what can happen when patients have access to one another's data. J Med Internet Res 2008;10(3):e15 [FREE Full text] [doi: 10.2196/jmir.1053] [Medline: 18504244]
15. Wicks P, Massagli M, Frost J, Brownstein C, Okun S, Vaughan T, et al. Sharing health data for better outcomes on PatientsLikeMe. J Med Internet Res 2010;12(2):e19 [FREE Full text] [doi: 10.2196/jmir.1549] [Medline: 20542858]
16. Forshew DA, Bromberg MB. A survey of clinicians' practice in the symptomatic treatment of ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2003 Dec;4(4):258-263. [Medline: 14753660] (Pubitemid 37428481)
17. Kurt A, Nijboer F, Matuz T, Kübler A. Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management. CNS Drugs 2007;21(4):279-291. [Medline: 17381183] (Pubitemid 46598449)
18. Walton SM, Schumock GT, Lee KV, Alexander GC, Meltzer D, Stafford RS. Prioritizing future research on off-label prescribing: results of a quantitative evaluation. Pharmacotherapy 2008 Dec;28(12):1443-1452. [doi: 10.1592/phco.28.12.1443] [Medline: 19025425]
19. Brown JN, Howard CA, Kemp DW. Modafinil for the treatment of multiple sclerosis-related fatigue. Ann Pharmacother 2010 Jun;44(6):1098-1103. [doi: 10.1345/aph.1M705] [Medline: 20442351]
20. Schwartz TL, Rayancha S, Rashid A, Chlebowksi S, Chilton M, Morell M. Modafinil treatment for fatigue associated with fibromyalgia. J Clin Rheumatol 2007 Feb;13(1):52. [doi: 10.1097/01.rhu.0000255801.32408.6e] [Medline: 17278955] (Pubitemid 46213848)
21. Randall DC, Cafferty FH, Shneerson JM, Smith IE, Llewelyn MB, File SE. Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndrome. J Psychopharmacol 2005 Nov;19(6):647-660. [doi: 10.1177/0269881105056531] [Medline: 16272188] (Pubitemid 41578828)
22. Turkington D, Hedwat D, Rider I, Young AH. Recovery from chronic fatigue syndrome with modafinil. Hum Psychopharmacol 2004 Jan;19(1):63-64. [doi: 10.1002/hup.554] [Medline: 14716715] (Pubitemid 38159279)
23. Nieves AV, Lang AE. Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil. Clin Neuropharmacol 2002;25(2):111-114. [Medline: 11981239] (Pubitemid 34411831)
24. Adler CH, Caviness JN, Hentz JG, Lind M, Tiede J. Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. Mov Disord 2003 Mar;18(3):287-293. [doi: 10.1002/mds.10390] [Medline: 12621632] (Pubitemid 36410825)
25. Ondo WG, Fayle R, Atassi F, Jankovic J. Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial. J Neurol Neurosurg Psychiatry 2005 Dec;76(12):1636-1639 [FREE Full text] [doi: 10.1136/jnnp.2005.065870] [Medline: 16291885] (Pubitemid 41697625)
26. Psaty BM, Ray W. FDA guidance on off-label promotion and the state of the literature from sponsors. JAMA 2008 Apr 23;299(16):1949-1951. [doi: 10.1001/jama.299.16.1949] [Medline: 18430914] (Pubitemid 351574925)